Coronavirus / COVID

Skilled nursing facilities are facing an unprecedented crisis as deaths rise amid the COVID-19 pandemic while admissions and patient census decline, a new study shows.

The mRNA-1273 vaccine candidate from Moderna will progress to a phase 3 trial in adults later this summer.

A modeling study from Imperial College shows the pandemic may have significant effect on mortality among other infectious disease patients.

A modeling study from Imperial College shows the pandemic may have significant effect on mortality among other infectious disease patients.

How a sexually-transmitted virus is hindered by limited marketing, and how its stigmas compare to those developing around COVID-19.

Pfizer and BioNTech were given approval by the federal agency to expedite their work on investigational vaccines.

Efforts to develop a COVID-19 vaccine must not skip important steps during clinical evaluation, experts explain.

Findings were announced during the special COVID-19 sessions of the virtual 23rd International AIDS Conference.

Over 200 scientists issued alert to medical community that COVID-19 is transmissible over longer distances via smaller aerosolized droplets.

Despite being within the age group at highest risk for severe SARS-CoV-2 infection, a recent survey suggests that the population is not inherently more willing to socially isolate.

A report released for AIDS 2020 warns the international AIDS response could be set back substantially by ongoing events.

How the inflammatory-based syndrome is affecting US children during the COVID-19 pandemic.

A discussion on how the pediatric inflammatory syndrome has begun to affect the US months into the pandemic.

Black Americans bear a disproportional burden and negative outcomes from the coronavirus.

A discussion with a Yale expert on what new CDC data shows.

Judith Feinberg, MD, FIDSA, describes ongoing investigation into the immune response from COVID-19.

The purchase by Health and Human Services ensures US hospitals can secure the COVID-19 medication for the next few months.

BNT162b1, a SARS-CoV-2 vaccine candidate, elicited promising early signs of immune activity in a placebo-controlled phase 1/2 study.

A brief overview of our top stories.

Jonathan Spero, MD, discusses workplace safety in the time of SARS-CoV-2.

Recent concerns have been raised about a spike protein mutation in SARS-CoV-2. Are these fears grounded?

With more COVID-19 cases being realized in the US, the White House Coronavirus Task Force testified before the Senate today.

New recommendations are intended to aid biomedical firms in achieving licensure of a safe and effective vaccine.

Judith Feinberg, MD, FIDSA, describes surprising outcomes in many COVID-19 cases among people living with HIV.

In a recent CDC Morbidity and Mortality Weekly Report, data showed greater intensive care unit admission and mechanical ventilation for this group of patients.